Home /EORTC 62113-55115

EORTC 62113-55115

Trial Description: 
A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment
Lead Cooperative Group: 
EORTC-GCG
Participating Groups: 
GOG
SGCTG
Trial Number: 

ClinicalTrials.gov Identifier: NCT01979393

Disease Site: 
Uterine Sarcoma
Trial Status: 
Recruiting
Contact person: 
iray